• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

LIVIN/BIRC7 (BIRC7) Antibody – Goat Polyclonal

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS420120

MBS420120 is an antibody targeting BIRC7. Also known as Goat anti-LIVIN/BIRC7 Antibody. Reactive in Tested: Human; Expected from sequence similarity: Human. Host: Goat. More details

$450 / 0.1 mg +1 FREE 8GB USB
Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
LIVIN/BIRC7, Polyclonal Antibody
Full Product Name
Goat anti-LIVIN/BIRC7 Antibody
Product Gene Name
Product Synonym Gene Name
LIVIN
Product Synonym Names
BIRC7; LIVIN; baculoviral IAP repeat-containing 7 (livin); KIAP; MLIAP; mliap; ML-IAP; livin inhibitor-of-apotosis; kidney inhibitor of apoptosis protein; melanoma inhibitor of apoptosis protein; baculoviral IAP repeat-containing protein 7; RNF50; livin i; BIRC7 antibody; LIVIN antibody; baculoviral IAP repeat-containing 7 (livin) antibody; KIAP antibody; MLIAP antibody; mliap antibody; ML-IAP antibody; livin inhibitor-of-apotosis antibody; kidney inhibitor of apoptosis protein antibody; melanoma inhibitor of apoptosis protein antibody; baculoviral IAP repeat-containing protein 7 antibody; RNF50 antibody; livin inhibitor of apoptosis antibody; LIVIN / BIRC7
Immunogen Sequence
RAPVRSRVRT
Clonality
Polyclonal
Host
Goat
Species Reactivity
Tested: Human; Expected from sequence similarity: Human
Form/Format
Supplied at 0.5 mg/ml in Tris saline, 0. 02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Purity/Purification
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Concentration
100ug specific antibody in 200ul (lot specific)
Preparation and Storage
Aliquot and store at -20 degree C. Minimize freezing and thawing.
Antibody/Peptide Pairs
Molecular Weight
30,866 Da
OMIM
605737
Immunogen
Peptide with sequence C-RAPVRSRVRT, from the C Terminus of the protein sequence according to NP_647478.1; NP_071444.1.
Epitope
C Terminus
Note
This antibody is expected to recognise both reported isoforms (as represented by NP_647478.1 and NP_071444.1)
ISO Certification
Manufactured in an ISO 9001:2008 Certified Laboratory.
Applications Tested/Suitable for anti-BIRC7 antibody
Peptide ELISA (EIA), Western Blot (WB)
Application Notes for anti-BIRC7 antibody
Peptide ELISA: Antibody detection limit dilution 1: 4000.
Western Blot: Approx 30kDa and 35kDa in lysates of celkl line Molt4, and 30kDa in lysates of Daudi, Jurkat and K562. These bands correspond to the reported isoforms with calculated MW of 32.8kDa according to NP_647478.1 and 30.9kDa according to NP_071444.1. Recommended concentration: 0.3 - 1 ug/ml.

Western Blot (WB) of anti-BIRC7 antibody

Staining (0.3ug/ml) of MOLT4 lysate (35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.
Goat Anti-BIRC7 Polyclonal Antibody – Cat# MBS420120

Western Blot (WB) of anti-BIRC7 antibody

Staining (0.5ug/ml) of Daudi (A), Jurkat (B) and K562 (C) lysates (35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.
Goat Anti-BIRC7 Polyclonal Antibody, Western Blot (WB) – Cat# MBS420120

Other Notes

Small volumes of anti-BIRC7 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Additional Details

NCBI/Uniprot data below describe general gene information for BIRC7. It may not necessarily be applicable to this product.

NCBI GI #
NCBI GeneID
NCBI Accession #
NCBI Related Accession #
UniProt Secondary Accession #
UniProt Related Accession #
GenBank Nucleotide #
NCBI Official Full Name
baculoviral IAP repeat-containing protein 7 isoform alpha
NCBI Official Synonym Full Names
baculoviral IAP repeat containing 7
NCBI Official Symbol
BIRC7
NCBI Official Synonym Symbols
KIAP; LIVIN; MLIAP; RNF50; ML-IAP
UniProt Protein Name
Baculoviral IAP repeat-containing protein 7
UniProt Synonym Protein Names
Kidney inhibitor of apoptosis protein; KIAP
UniProt Gene Name
BIRC7
UniProt Synonym Gene Names
KIAP; LIVIN; MLIAP; RNF50; KIAP; ML-IAP; Truncated livin; p30-Livin; tLivin
UniProt Entry Name
BIRC7_HUMAN
NCBI Protein Information
baculoviral IAP repeat-containing protein 7

NCBI Summary for BIRC7

This gene encodes a member of the inhibitor of apoptosis protein (IAP) family, and contains a single copy of a baculovirus IAP repeat (BIR) as well as a RING-type zinc finger domain. The BIR domain is essential for inhibitory activity and interacts with caspases, while the RING finger domain sometimes enhances antiapoptotic activity but does not inhibit apoptosis alone. Elevated levels of the encoded protein may be associated with cancer progression and play a role in chemotherapy sensitivity. Alternative splicing results in multiple transcript variants [provided by RefSeq, Jul 2013]
Show more

UniProt Comments for BIRC7

BIRC7: Apoptotic regulator capable of exerting proapoptotic and anti-apoptotic activities and plays crucial roles in apoptosis, cell proliferation, and cell cycle control. Its anti-apoptotic activity is mediated through the inhibition of CASP3, CASP7 and CASP9, as well as by its E3 ubiquitin-protein ligase activity. As it is a weak caspase inhibitor, its anti-apoptotic activity is thought to be due to its ability to ubiquitinate DIABLO/SMAC targeting it for degradation thereby promoting cell survival. May contribute to caspase inhibition, by blocking the ability of DIABLO/SMAC to disrupt XIAP/BIRC4-caspase interactions. Protects against apoptosis induced by TNF or by chemical agents such as adriamycin, etoposide or staurosporine. Suppression of apoptosis is mediated by activation of MAPK8/JNK1, and possibly also of MAPK9/JNK2. This activation depends on TAB1 and NR2C2/TAK1. In vitro, inhibits CASP3 and proteolytic activation of pro-CASP9. Isoform 1 blocks staurosporine-induced apoptosis. Isoform 2 blocks etoposide-induced apoptosis. Isoform 2 protects against natural killer (NK) cell killing whereas isoform 1 augments killing. Binds to CASP9. Interaction with DIABLO/SMAC via the BIR domain disrupts binding to CASP9 and apoptotic suppressor activity. Interacts with TAB1. In vitro, interacts with CASP3 and CASP7 via its BIR domain. Isoform 1 and isoform 2 are expressed at very low levels or not detectable in most adult tissues. Detected in adult heart, placenta, lung, lymph node, spleen and ovary, and in several carcinoma cell lines. Isoform 2 is detected in fetal kidney, heart and spleen, and at lower levels in adult brain, skeletal muscle and peripheral blood leukocytes. Belongs to the IAP family. 2 isoforms of the human protein are produced by alternative splicing.

Protein type: Apoptosis; Ubiquitin ligase; Ubiquitin conjugating system; EC 6.3.2.-; Ligase

Chromosomal Location of Human Ortholog: 20q13.3

Cellular Component: cytoplasm; Golgi apparatus; nucleus; spindle microtubule

Molecular Function: cysteine protease inhibitor activity; enzyme binding; ligase activity; protein binding; ubiquitin-protein ligase activity; zinc ion binding

Biological Process: activation of JNK activity; negative regulation of apoptosis; protein ubiquitination; regulation of cell proliferation; regulation of signal transduction
Show more

Precautions

All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.

Disclaimer

While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.

Product Note

Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.

Product PubMed Publications

Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000